Predicate |
Object |
contentType |
Journal Article|Review |
endingPage |
319 |
issn |
1074-2484 1940-4034 |
issueIdentifier |
4 |
pageRange |
310-319 |
publicationName |
Journal of Cardiovascular Pharmacology and Therapeutics |
startingPage |
310 |
bibliographicCitation |
Frishman WH. β-Adrenergic blockade in cardiovascular disease. J Cardiovasc Pharmacol Ther. 2013 Jul;18(4):310–9. doi: 10.1177/1074248413484986. PMID: 23637119. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_16ef838e76b71fa45c622d2ed64c78e5 |
date |
2013-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://doi.org/10.1177/1074248413484986 https://pubmed.ncbi.nlm.nih.gov/23637119 |
isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21636 https://portal.issn.org/resource/ISSN/1074-2484 https://portal.issn.org/resource/ISSN/1940-4034 |
language |
English |
source |
https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ |
title |
β-Adrenergic Blockade in Cardiovascular Disease |
discusses |
http://id.nlm.nih.gov/mesh/M0000495 |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7181 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fc1b42f44aeb9011478ed85af58220a1 |